Emerging technologies in the medical devices industry are upheaving traditional tools for patient care, and “Bionic Healthcare” companies are among the foremost innovators within this growing sector. Technology capable of allowing the blind to see, the paralyzed to walk, or predicting strokes prior to clinical examination would undeniably transform healthcare opportunities for patients with medical conditions that were previously thought to be uncurable. The MVIS® Global Bionic Healthcare ESG Index tracks the performance of companies that are specifically engaged in this revolution of healthcare delivery. 

View pdf >